Table 2 Stage I-IIA patients’ characteristics and clinical features
Parameters | Group (no.) | MST (mo) | HR | P |
|---|---|---|---|---|
FIGO | I (53) | 69 | ||
II (23) | 49 | 2.291 (1.155–4.544) | 0.018 | |
Size | ⩽4 cm (44) | 67 | ||
>4 cm (32) | 52 | 1.981 (0.997–3.937) | 0.051 | |
LNM | No (46) | 70 | ||
Yes(22) | 45 | 2.723 (1.294–5.729) | 0.008 | |
LVSI | No (44) | 69 | ||
Yes (24) | 46 | 2.367 (1.121–4.999) | 0.024 | |
DOI | ⩽2/3 (53) | 66 | ||
>2/3 (15) | 32 | 2.102 (0.856–5.163) | 0.105 | |
NACT | No (34) | 63 | ||
Yes (34) | 61 | 1.111 (0.520–2.373) | 0.785 | |
Radiotherapy | No (49) | 61 | ||
Yes (19) | 37 | 1.864 (0.835–4.163) | 0.129 |